Single vs. Multiple Fraction Trial of Stereotactic Ablative Radiotherapy for Comprehensive Treatment of Oligometastases/Progression

Conditions:   Oligometastatic Disease;   Oligoprogression;   Toxicity Due to Radiotherapy;   Quality of Life Interventions:   Radiation: Single fraction SABR;   Radiation: Multiple fraction SABR;   Other: QoL reporting alone;   Other: QoL reporting, symptom screen and healthcare provider intervention Sponsors:   British Columbia Cancer Agency;   London Regional Cancer Program, Canada;   Tom Baker Cancer Centre;   Princess Margaret Hospital, Canada Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials